NewAmsterdam Pharma N.V.

8.99
-1.47 (-14.05%)
At close: Mar 31, 2025, 3:55 PM

NewAmsterdam Pharma Ratios Statement

Year FY24 FY23 FY22 FY21 FY20
PE Ratio -10.04 -5.19 -9.78 -4.71 -32.77
PEG Ratio -0.53 -0.06 0.15 -0.02 n/a
PS Ratio 53.22 71.91 2.16 n/a n/a
PB Ratio 3.20 3.18 0.43 3.48 -52.66
P/FCF Ratio -15.23 -6.5 25.97 -6.87 -31.48
P/OCF Ratio -15.29 -6.5 25.93 -6.88 -31.55
OCF/S Ratio -3.48 -11.06 0.08 n/a n/a
Debt / Equity Ratio 0.00 0.00 0.00 0.00 -3.26
Quick Ratio 8.08 6.95 12.64 5.96 0.72
Current Ratio 8.08 6.95 12.64 5.96 0.72
Asset Turnover 0.05 0.04 0.18 n/a n/a
Interest Coverage n/a -24.38 n/a n/a n/a
Return on Equity (ROE) -0.32 -0.61 -0.04 -0.74 1.61
Return on Assets (ROA) -0.28 -0.51 -0.04 -0.61 -0.62
Return on Capital (ROIC) -0.23 -0.56 -0.01 -0.62 1.52
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin 100.00% 100.00% 100.00% n/a n/a
Net Profit Margin -530.25% -1.39K% -22.04% n/a n/a
Pretax Profit Margin -530.25% -1.26K% -22.04% n/a n/a
Operating Profit Margin -386.91% -1.3K% -3.46% n/a n/a
FCF Margin -349.49% -1.11K% 8.30% n/a n/a
EBITDA Margin -530% -1.39K% -3.45% n/a n/a